Navigation Links
Multi Frequency Linear Breast HST Transducer UST-5542

ProductsMulti Frequency Linear Breast HST Transducer UST-5542
Company ALOKA, Inc.
Item Multi Frequency Linear Breast HST Transducer UST-5542
Features 
  • Multiple frequencies
  • Superior image quality
  • Includes Hemispheric Sound Technology and PixelFocus
  • Provides good resolution and detail for breast imaging
  • Ideal for imaging the shoulder, elbow, hand, wrist, knee, foot and ankle
  • Compatible with Aloka Ultrasound Consoles: SSD-4000, SSD-3500
Description Linear high frequency (13Mhz) transducer for breast and superficial imaging. Incorporates ALOKAs exclusive Hemispheric Sound Technology and PixelFocus, technologies. This multi-frequency transducer provides exceptional resolution and detail for breast imaging.
Info ALOKA, Inc.
Customer Service: (800) 872-5652
Web site: http://www.aloka.com

Related medicine products :

1. Black Multi-Pinhole Occluder
2. ReNu MultiPlus Multi-Purpose Solution
3. Renu Multi-Purpose Solution
4. Opti-One Multi-Purpose Solution
5. Solo-Care Brand Multipurpose Solution
6. Renu MultiPlus Multi-Purpose Solution No Rub Formula
7. Renu Multiplus Lubricating and Rewetting Drops
8. Renu Multiplus Multi-Purpose Solution No Rub Formula
9. Multi-Purpose Stand Magnifier
10. Soflens Multi-Focal
11. Frequency 55 Multifocal
... GE Healthcares new Vivid i ... cardiovascular ultrasound system to provide high-performance, full-featured ... Vivid i addresses one ... access to complete, real-time diagnostic information. ...
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i...
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... The Veris physiological monitor offers a comprehensive ... specifically designed for pediatric and neonate patients, ... to 3T. Veris is the first MR ... of pediatric and neonate patient monitoring. The ...
Medicine Products:
(Date:12/7/2009)... Today the Centers for Disease Control and Prevention (CDC) ... the week was designed to highlight the importance of ... of taking additional steps to keep you and your ... of December, January and beyond. ,, "It,s easy to ... topic of both seasonal and swine flu," said Dr. ...
(Date:12/6/2009)... BROOK, Ill., Dec. 7 The University ... (AMC) members for their achievements in UHC,s Supply ... organizations are noted for modeling best practices in ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined ... that includes contract portfolio participation and use of ...
(Date:12/6/2009)... future treatments targeting growth factor, researchers say , , ... breast cancer cells from the main tumor to other ... factor known as TGFb, which may prove a promising ... British researchers say. , Previous studies have shown that ... and movement. In this new study, a team from ...
(Date:12/6/2009)... Dec. 6 Blood clotting, or coagulation, ... when a blood vessel is injured. Sometimes, however, ... an obvious injury or do not dissolve naturally, ... today at the 51st Annual Meeting of the ... of using the anticoagulants aspirin and heparin with ...
(Date:12/5/2009)... shown in a phase 1/2 clinical trial that ... of patients newly diagnosed with multiple myeloma, a cancer ... from Dana-Farber Cancer Institute. , Partial responses or better ... with the drug combination in the multi-center study, with ... in the phase 2 population, reports Paul G. Richardson, ...
Breaking Medicine News(10 mins):Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... Provide General Information about Potential Health ConcernsNEWTON, Mass., May ... in the reinvention of how people obtain legal services, ... general information about the potential health hazards of excessive ... consumer product used by an estimated 35 million Americans ...
... colleague Tom Daulton to provide strategic leadership as ... PRAIRIE, Wis., May 5 Devicor Medical Products, ... Executive Vice President, Corporate Development & Strategy. Salkin,s ... the Royal Bank of Scotland plc is highlighted ...
... BERLIN, May 5 Anatomist, Dr. Gunther von Hagens, ... set out three years ago to present the human ... his "HUMAN SAGA" project this week.(Photo: http://www.newscom.com/cgi-bin/prnh/20090505/CG11117 ... hoped to traverse the anatomical landscape left uncharted by ...
... According to a new study led by researchers at ... several factors that contribute to children missing immunization visits. ... presentation at 8:30 a.m. ET on Tuesday, May 5, ... here. , "We know that approximately 20 percent ...
... Will Host ,Day of Dialogue, Online Town Hall Meeting on ... America,s healthcare and long-term services need to undergo a ... seniors and people with disabilities, according to a report released ... report, which will be supported by a nationwide "Day of ...
... Health Care Management WASHINGTON, May 5 ... education organization, announced today that Christine G. Leyden, Senior ... Accreditation Officer for URAC has been recognized as a ... Point magazine. Ms. Leyden will be featured in ...
Other Medicine News:Health News:Sokolove Law Launches Denture Cream Consumer Hotline 2Health News:Jonathan Salkin Named Executive Vice President of Devicor Medical Products 2Health News:Dr. Gunther von Hagens 'HUMAN SAGA' Project Presents Sexuality and Reproduction in New Exhibit, The Cycle of Life. 2Health News:Why parents miss their children's immunization visits 2Health News:Why parents miss their children's immunization visits 3Health News:National Advisory Board Issues 'Declaration for Independence': A Call-to-Action in Healthcare for Seniors and People with Disabilities 2Health News:National Advisory Board Issues 'Declaration for Independence': A Call-to-Action in Healthcare for Seniors and People with Disabilities 3Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 2Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 3
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
(Date:12/4/2009)... N.Y., Dec. 4 Bayer Diabetes Care today announced the ... Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the ... the country. The grand prize is an in-person meeting today ... 1 diabetes like Nick, are: Caleb, age 6, from Danbury, ...
(Date:12/4/2009)... AstraZeneca (NYSE: AZN ) today announced that ... once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as ... Depressive Disorder (MDD). SEROQUEL XR is the only medication ... both major depressive disorder as adjunctive therapy and acute ...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leg Clots May Not Travel to Lungs 59796 1Leg Clots May Not Travel to Lungs 59796 2Leg Clots May Not Travel to Lungs 59796 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 1Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 3